| |
| |
|
| Insider
Information: |
Dodion Pierre F |
| Relationship: |
SVP, Corp. Dev. & Oper... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
102,532 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
102,532 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ariad Pharmaceuticals Inc |
ARIA |
SVP, Corp. Dev. & Oper... |
2013-11-22 |
102,532 |
2010-05-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corp. Dev. & Operations |
• • – |
2013-11-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
35,250 |
102,532 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corp. Dev. & Operations |
• • – |
2013-07-18 |
4 |
AS |
$19.79 |
$126,655 |
D/D |
(6,400) |
67,282 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corp. Dev. & Operations |
• • – |
2013-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,000 |
73,682 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corp. Dev. & Operations |
• • – |
2013-04-02 |
4 |
S |
$18.04 |
$43,295 |
D/D |
(2,400) |
57,682 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corp. Dev. & Operations |
• • – |
2013-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
60,082 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corp. Dev. & Operations |
• • – |
2013-03-25 |
4 |
S |
$18.87 |
$153,482 |
D/D |
(8,133) |
54,082 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corp. Dev. & Operations |
• • – |
2013-03-22 |
4 |
S |
$19.46 |
$46,698 |
D/D |
(2,400) |
41,882 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corp. Dev. & Operations |
• • – |
2013-03-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,333 |
62,215 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corp. Dev. & Operations |
• • – |
2013-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
44,282 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corp. Dev. & Operations |
• • – |
2012-12-18 |
4 |
D |
$20.18 |
$75,836 |
D/D |
(3,758) |
38,282 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corp. Dev. & Operations |
• • – |
2012-12-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,000 |
42,040 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corp. Dev. & Operations |
• • – |
2012-07-30 |
4 |
AS |
$19.00 |
$543,400 |
D/D |
(28,600) |
33,040 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corp. Dev. & Operations |
• • – |
2012-07-30 |
4 |
OE |
$5.49 |
$137,250 |
D/D |
25,000 |
61,640 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corp. Dev. & Operations |
• – – |
2012-04-12 |
4 |
AS |
$15.39 |
$262,576 |
D/D |
(17,062) |
58,770 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corp. Dev. & Operations |
• – – |
2012-04-03 |
4 |
AS |
$16.18 |
$38,836 |
D/D |
(2,400) |
75,832 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corp. Dev. & Operations |
• – – |
2012-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
78,232 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corp. Dev. & Operations |
• – – |
2012-03-26 |
4 |
AS |
$16.50 |
$412,500 |
D/D |
(25,000) |
72,232 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corp. Dev. & Operations |
• – – |
2012-03-26 |
4 |
OE |
$5.49 |
$137,250 |
D/D |
25,000 |
97,232 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corp. Dev. & Operations |
• – – |
2012-03-23 |
4 |
AS |
$14.41 |
$380,712 |
D/D |
(24,901) |
72,232 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corp. Dev. & Operations |
• – – |
2012-03-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,333 |
97,133 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corp. Dev. & Operations |
• – – |
2012-03-20 |
4 |
S |
$15.01 |
$194,799 |
D/D |
(12,980) |
76,800 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Corp. Dev. & Operations |
• – – |
2012-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
59,000 |
89,780 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Corp. Development |
• – – |
2011-04-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
38,718 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Corp. Development |
• – – |
2011-04-11 |
4 |
D |
$7.76 |
$61,599 |
D/D |
(7,938) |
30,780 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Corp. Development |
• – – |
2011-03-22 |
4 |
D |
$6.39 |
$42,276 |
D/D |
(6,616) |
13,718 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
